Evidence map›Paper›PMID 33370400›Full record

ArticlePLoS pathogens2020

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.

Tomohiro Akahoshi, Hiroyuki Gatanaga, Nozomi Kuse, Takayuki Chikata, Madoka Koyanagi, Naoki Ishizuka, Chanson J Brumme, Hayato Murakoshi, Zabrina L Brumme, Shinichi Oka and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Tomohiro AkahoshiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Hiroyuki GatanagaDivision of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Tokyo, Japan.
Nozomi KuseCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Takayuki ChikataCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Madoka KoyanagiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-0432-8324
Naoki IshizukaCancer Institute Hospital of JFCR, Tokyo, Japan.
Chanson J BrummeBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.ORCID 0000-0003-2722-5288
Hayato MurakoshiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Zabrina L BrummeBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.ORCID 0000-0002-8157-1037
Shinichi OkaDivision of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Tokyo, Japan.
Masafumi TakiguchiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-8516-6442
Kumamoto University · JPNational Center for Global Health and Medicine · JPSimon Fraser University · CAThe Cancer Institute Hospital · JPUniversity of British Columbia · CA

Funding

CIHR PJT-148621
6 · The paper itself

Abstract

HIV-1 strains harboring immune escape mutations can persist in circulation, but the impact of selection by multiple HLA alleles on population HIV-1 dynamics remains unclear. In Japan, HIV-1 Reverse Transcriptase codon 135 (RT135) is under strong immune pressure by HLA-B*51:01-restricted and HLA-B*52:01-restricted T cells that target a key epitope in this region (TI8; spanning RT codons 128-135). Major population-level shifts have occurred at HIV-1 RT135 during the Japanese epidemic, which first affected hemophiliacs (via imported contaminated blood products) and subsequently non-hemophiliacs (via domestic transmission). Specifically, threonine accumulated at RT135 (RT135T) in hemophiliac and non-hemophiliac HLA-B*51:01+ individuals diagnosed before 1997, but since then RT135T has markedly declined while RT135L has increased among non-hemophiliac individuals. We demonstrated that RT135V selection by HLA-B*52:01-restricted TI8-specific T-cells led to the creation of a new HLA-C*12:02-restricted epitope TN9-8V. We further showed that TN9-8V-specific HLA-C*12:02-restricted T cells selected RT135L while TN9-8T-specific HLA-C*12:02-restricted T cells suppressed replication of the RT135T variant. Thus, population-level accumulation of the RT135L mutation over time in Japan can be explained by initial targeting of the TI8 epitope by HLA-B*52:01-restricted T-cells, followed by targeting of the resulting escape mutant by HLA-C*12:02-restricted T-cells. We further demonstrate that this phenomenon is particular to Japan, where the HLA-B*52:01-C*12:02 haplotype is common: RT135L did not accumulate over a 15-year longitudinal analysis of HIV sequences in British Columbia, Canada, where this haplotype is rare. Together, our observations reveal that T-cell responses to sequentially emerging viral escape mutants can shape long-term HIV-1 population dynamics in a host population-specific manner.

Indexed as

HIV-1HIV InfectionsAntigenic VariationCells, CulturedClonal EvolutionEpitopes, T-LymphocyteHeLa CellsHIV SeropositivityHost AdaptationHost-Pathogen InteractionsHumansImmune EvasionMolecular TypingMutationT-Lymphocytes, CytotoxicViral LoadEpitopes, T-Lymphocyte

Identifiers

PMID33370400
PMCPMC7833229
OpenAlexW3115815493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.